Gio Gonzalez has high ankle sprain, will be replaced on the NLCS roster

Getty Images
2 Comments

It was understandable if you forgot about it given that it happened hours and hours before the end of the game, but Gio Gonzalez left in the second inning of Game 4 of the NLCS after coming down funny on his ankle while fielding a ball in play.

While Gonzalez attempted to stay in the game after that it was clear that he was not right, so the Brewers went to the bullpen. After the game, it was clear why he wasn’t right: Brewers manager Craig Counsell said that Gonzalez had a high ankle sprain and that it was likely he would be replaced on the roster with another pitcher.

This may actually benefit Milwaukee in the very short term given that Milwaukee used six relievers last night, so there will be a fresh arm on staff for Game 5 tonight. It does mean, however, that Gonzalez’ season is over, as a player replaced due to injury in one playoff series is required to sit out the next one. If the Brewers make it to the World Series, Gonzalez will not be available no matter how he is health, wise.

Counsell did not say which pitcher will replace Gonzalez on the roster. We’ll find out for sure later today. Among the possibilities are Chase Anderson, Zach Davies, Jordan Lyles and Matt Albers.

MLB, union resume blood testing after pandemic, lockout

Scott Taetsch-USA TODAY Sports
1 Comment

NEW YORK – In the first acknowledgment that MLB and the players’ association resumed blood testing for human growth hormone, the organizations said none of the 1,027 samples taken during the 2022 season tested positive.

HGH testing stopped in 2021 because of the COVID-19 pandemic. Testing also was halted during the 99-day lockout that ended in mid-March, and there were supply chain issues due to COVID-19 and additional caution in testing due to coronavirus protocols.

The annual public report is issued by Thomas M. Martin, independent program administrator of MLB’s joint drug prevention and treatment program. In an announcement accompanying Thursday’s report, MLB and the union said test processing is moving form the INRS Laboratory in Quebec, Canada, to the UCLA Laboratory in California.

MLB tests for HGH using dried blood spot testing, which was a change that was agreed to during bargaining last winter. There were far fewer samples taken in 2022 compared to 2019, when there were 2,287 samples were collected – none positive.

Beyond HGH testing, 9,011 urine samples were collected in the year ending with the 2022 World Series, up from 8,436 in the previous year but down from 9,332 in 2019. And therapeutic use exemptions for attention deficit hyperactivity disorder dropped for the ninth straight year, with just 72 exemptions in 2022.

Overall, the league issued six suspensions in 2022 for performance-enhancing substances: three for Boldenone (outfielder/first baseman Danny Santana, pitcher Richard Rodriguez and infielder Jose Rondon, all free agents, for 80 games apiece); one each for Clomiphene (Milwaukee catcher Pedro Severino for 80 games), Clostebol (San Diego shortstop Fernando Tatis Jr. for 80 games) and Stanozolol (Milwaukee pitcher J.C. Mejia for 80 games).

There was an additional positive test for the banned stimulant Clobenzorex. A first positive test for a banned stimulant results in follow-up testing with no suspension.